Alignment Healthcare Inc (ALHC) Investment Analysis:
1. Executive Summary:
Alignment Healthcare Inc (ALHC) functions as a specialized, consumer-centric healthcare platform that has fundamentally redefined the delivery model for Medicare Advantage (MA) services in the United States.[1, 2] Established in 2013 and headquartered in Orange, California, the company targets the senior population, specifically those eligible for Medicare who opt for private insurance alternatives.[1, 3] The organization’s primary objective is the delivery of high-quality, low-cost care through a vertically integrated ecosystem that combines proprietary technology, a dedicated clinical model, and a robust consumer brand known as Alignment Health Plan.[1, 4]
Revenue is primarily generated through earned premiums, where Alignment enters into risk-bearing contracts with the Centers for Medicare & Medicaid Services (CMS).[5, 6] Under this capitated payment model, the company receives a fixed monthly fee per member to manage their comprehensive healthcare needs, allowing it to capture the financial benefits of improved clinical outcomes and reduced hospitalizations.[4, 7] These revenues are supplemented by a portfolio of diverse plan options, including Health Maintenance Organizations (HMOs), Preferred Provider Organizations (PPOs), and highly specialized Special Needs Plans (SNPs) tailored for members with chronic conditions (C-SNPs) or those dually eligible for Medicare and Medicaid (D-SNPs).[1, 8]
The company's primary customer types are seniors aged 65 and older, with a particular focus on high-acuity, chronically ill, and frail populations who require intensive care coordination.[2, 9] Geographically, while the company maintains a dominant legacy presence in the California market, it has aggressively expanded its footprint into North Carolina, Nevada, Arizona, and Texas.[9, 10, 11] Alignment currently serves approximately 284,800 members as of the first quarter of 2026, representing a 30.9% year-over-year increase.[12, 13]
Customers frequently choose Alignment over larger, legacy alternatives such as UnitedHealth or Humana due to its differentiated "Seniors First" philosophy, which manifests in superior service levels and clinical outcomes.[3, 4] A critical differentiator is the 24/7 ACCESS On-Demand Concierge program, which provides members with a dedicated team for care navigation, alongside a proprietary technology platform named AVA® that enables predictive care.[2, 4, 14] Furthermore, the company’s ability to maintain high Star Ratings—with 100% of members in plans rated 4 stars or higher for the second consecutive year—ensures that it can offer more robust supplemental benefits, such as grocery and transportation allowances, compared to lower-rated competitors.[9, 15] PROFITABLE GROWTH DISRUPTOR
2. Business Drivers & Strategic Overview:
The strategic architecture of Alignment Healthcare is built upon a "virtuous cycle" where superior technology and clinical rigor drive better health outcomes, leading to higher government quality ratings and, consequently, higher bonus payments that are reinvested into member benefits to drive further growth.[4] This cycle is powered by three primary business drivers: membership expansion, medical cost management through artificial intelligence, and operational leverage via administrative automation.[4, 16, 17]
Product and Service Detail
Alignment sells more than just an insurance policy; it sells an integrated care experience. The core products are its Medicare Advantage plans, which serve as a comprehensive alternative to traditional Medicare.[7] These plans often feature $0 premiums, $0 copays for primary care visits, and $0 inpatient hospital costs in certain high-performing markets like Nevada.[18, 19]
To understand what is actually being sold, an investor must look at the specific "wrap-around" services that differentiate the plan. These include the ACCESS On-Demand Concierge Card, an all-in-one debit card that provides monthly spending allowances for over-the-counter (OTC) items and groceries.[8, 19] In El Paso, for instance, certain D-SNP plans offer up to a $193 monthly combined allowance.[8] The concierge team available through this card is not merely a call center; it is a clinical and administrative hub that can arrange palliative care within 48 hours or coordinate transportation for a member with complex social needs.[2]
The clinical model is another critical component of the "product." Alignment employs internal care teams and partners with select providers to deliver "Care Anywhere," including in-home clinical visits and virtual care through a dedicated virtual care center.[2, 14, 20] This high-touch approach is designed to manage "high acuity" populations, which grew by approximately 50% in 2026.[17, 21]
Moat Analysis: Technology, Quality, and Scale
Alignment Healthcare possesses several structural advantages that constitute a significant economic moat:
- Proprietary Technology (IP): The AVA® (Alignment Virtual Application) platform is the company’s primary intellectual property moat. AVA aggregates millions of data points across the healthcare continuum to assess member health through more than 160 artificial intelligence models.[2, 22] This allows care teams to predict risks for hospitalization or disease propensity before they become emergencies.[2, 22] Unlike legacy insurers that often use third-party software, Alignment’s purpose-built stack allows for rapid iteration and deep clinical integration.[2, 23]
- Regulatory & Quality Advantage: The CMS Star Rating system is a powerful barrier to entry. Plans with 4 stars or higher receive Quality Bonus Payments (QBP) that are essential for funding the rich supplemental benefits that attract new members.[10, 24] Maintaining 100% of members in 4-star plans or better provides a significant cost-of-capital and pricing advantage over competitors who have seen their ratings slip.[15, 24]
- Cost Advantage through Automation: Alignment is aggressively automating its administrative functions. The claims auto-adjudication rate surged from under 15% in 2025 to over 60% in early 2026.[12, 16, 17] This transition directly lowers the Selling, General, and Administrative (SG&A) expense ratio, creating a cost advantage as the business scales.[16, 17]
- Brand and Switching Costs: The senior market is characterized by high inertia. Alignment’s high Net Promoter Score (60+) and its 20% improvement in voluntary disenrollment metrics suggest a brand that creates strong emotional and functional ties.[4, 9] Once a member is integrated into the "concierge" ecosystem, the perceived cost of switching to a less responsive legacy plan is high.[4]
TAM / Market Opportunity Analysis
The market opportunity for Alignment is rooted in the "silver tsunami" of an aging U.S. population. The Medicare Advantage market reached a record 35.4 million beneficiaries in 2026, with a penetration rate of 51% of all Medicare-eligible individuals.[25] This represent a 2.5% growth from 2025, a deceleration from the 7-10% seen in the early 2020s, but still a massive absolute market.[25, 26]
Alignment’s goal is to reach 1 million members, a significant leap from its current ~285,000.[9, 17] The company has a current footprint in 45 markets across five states, covering approximately 8.3 million Medicare-eligible adults.[8, 11] Crucially, Alignment holds less than 4% market share in the counties it serves outside of California, implying a substantial opportunity for same-store growth simply by gaining parity with its California market share.[9, 11]
Competitive Landscape
The landscape is currently a "barbell" structure, with massive legacy incumbents on one end and agile "insurtech" startups on the other.
- Legacy Nationals: UnitedHealth Group and Humana control 46% of the market.[27] These companies have scale but are currently facing margin pressure due to high utilization and the transition to the V28 risk model.[9, 25] Alignment is successfully taking share from these players; in the 2026 enrollment period, Alignment grew membership by 31% while many nationals shed members to preserve profitability.[10, 15, 25]
- Next-Gen Peers: Competitors like Devoted Health and Clover Health are also technology-focused. Devoted grew 120% in 2026, while Clover has struggled with its Star Ratings.[24, 25] Alignment differentiates itself by being one of the few next-gen players to achieve GAAP profitability while maintaining high Star Ratings.[9, 12, 28]
- Regional Non-Profits: Organizations like Blue Cross Blue Shield of NC often have strong local ties but often lag in technology-driven clinical management.[8, 26]
Alignment is currently gaining ground, particularly in markets where legacy players have reduced benefits to offset rising medical costs.[25, 29] By maintaining benefit stability and quality, Alignment has positioned itself as the premium choice for seniors.[8, 15] AI-POWERED CLINICAL SUPERIORITY
3. Financial Performance & Valuation:
Alignment Healthcare's first quarter of 2026 marks the most significant financial milestone in its history: the transition to GAAP profitability while maintaining high-double-digit growth.[12, 13]
Q1 2026 Financial Results Analysis
The company reported its Q1 2026 results on April 30, 2026.[6, 12]
- Revenue Performance: Total revenue was $1.235 billion, representing a 33.3% year-over-year increase, driven by a 30.9% rise in health plan membership.[12, 13, 23] This result slightly exceeded the analyst consensus of $1.22 billion.[12]
- Earnings per Share (EPS): The company reported a diluted EPS of $0.05, significantly outperforming the analyst expectation of $0.01.[12] This represents a 400% surprise and a massive turnaround from the $0.05 loss per share in Q1 2025.[5, 12]
- Net Income: GAAP net income reached $11.4 million, compared to a net loss of $9.4 million in the prior-year period.[13, 23]
- Adjusted EBITDA: This metric rose 87.6% year-over-year to $37.9 million, with an adjusted EBITDA margin of 3.1%, a 90 basis-point expansion.[13, 16, 17]
- Medical Benefit Ratio (MBR): The MBR improved by 20 basis points to 88.2%, despite a "headwind" from a CMS process change in observation determinations that pushed inpatient admissions toward the high 150s per thousand members.[12, 16]
- SG&A Efficiency: Adjusted SG&A improved by 60 basis points as a percentage of revenue to 8.7%, reflecting the impact of claims automation.[12, 16]
Guidance and Management Commentary
Following the strong Q1 performance, the company raised its full-year 2026 guidance.[12, 13]
| Metric |
FY 2026 Guidance (Raised) |
FY 2026 Guidance (Previous Midpoint) |
| Membership |
294,000 – 299,000 |
295,000 |
| Revenue |
$5.160B – $5.205B |
$5.162B |
| Adjusted Gross Profit |
$620M – $650M |
$632.5M |
| Adjusted EBITDA |
$138M – $163M |
$148M |
Data sources: [13, 16, 17, 23]
Management commentary from the earnings call emphasized "disciplined growth" and the "replicability" of the model.[9, 23] CEO John Kao highlighted that the company is "absorbing headwinds" while still beating on the bottom line, which suggests a high degree of operational resilience.[12, 16] CFO James Head noted that approximately 60% of full-year EBITDA is expected to be generated in the first half of 2026, reflecting the seasonality of the Medicare Advantage business.[16, 17]
Valuation and Financial Drivers
The market’s valuation of Alignment Healthcare is beginning to shift from a purely growth-based P/S multiple to a more traditional earnings and EBITDA framework.
- Current Price: $17.93 (as of May 8, 2026).[30, 31]
- Price-to-Sales (P/S): 0.94x.[30, 32] This is a discount compared to its trailing 12-month average of 1.2x and its 2021-2022 levels above 2.0x.[32]
- Enterprise Value-to-EBITDA (EV/EBITDA): Based on the midpoint of 2026 guidance ($150.5M), the forward EV/EBITDA is approximately 23x-25x (assuming net debt considerations).[30, 33]
- Price-to-Earnings (P/E): Forward P/E is roughly 105x, but analysts expect earnings to grow by 147% in the coming year, leading to a PEG ratio of 2.78.[30]
Long-Term Financial Drivers:
1. Sales Growth (5-Year CAGR): The historical 5-year CAGR is 33%.[34] Future growth is projected at 28% annually through 2031.[34]
2. MBR Stability: The core valuation assumption is that Alignment can keep MBR between 87-88% while expanding into more complex "high acuity" populations.[9, 11]
3. Automation of SG&A: The company expects its auto-adjudication rate (currently >60%) to continue rising, potentially lowering SG&A as a percentage of revenue by another 100-200 basis points over 5 years.[16, 17]
4. Capital Efficiency: Alignment produced positive free cash flow in 2025 and ended Q1 2026 with $726 million in liquidity, reducing the need for dilutive equity raises to fund expansion.[16, 21, 35]
The market reaction to the latest earnings was initially positive (up 3.78%) but turned slightly negative in aftermarket trading (-0.64%) as investors digested a secondary offering from a major shareholder.[12, 36] However, the fundamental picture of "profitable growth at scale" has stayed intact.[33] PROFITABLE SCALE ACHIEVED
4. Risk Assessment & Macroeconomic Considerations:
A rigorous evaluation of Alignment Healthcare identifies a multi-faceted risk profile that investors must balance against its high-growth potential. These risks range from granular operational hurdles to broad regulatory shifts.
Company-Specific Execution Risks
- Scaling of Clinical Model: The primary risk is the potential failure of the "high-touch" clinical model as it scales beyond California.[1, 9] While ex-California membership grew 80% in 2026, these markets are less mature.[9] If the company cannot recruit high-quality local provider partners or if the AVA platform fails to accurately predict local utilization trends, MBR could spike unexpectedly.[9, 16]
- Retention of Key Talent: The business is heavily reliant on the vision of John Kao and his executive team.[1, 3] While compensation is aligned through PSUs and RSUs, any significant leadership transition could disrupt the delicate balance between clinical rigor and technological innovation.[7, 37]
- Infrastructure Stress: The rapid expansion from ~236k to ~285k members in one year puts immense pressure on internal systems.[13, 35] Any delay in the rollout of the AVA AI contract management tools or failures in the new claims automation could lead to operational bottlenecks.[17]
Competitive & Industry Structure Risks
- Concentration in California: Despite expansion, California remains the primary revenue and profit driver.[9, 10] Changes in California’s state-level reimbursement or increased competitive intensity from players like SCAN or Kaiser Permanente could disproportionately impact the consolidated results.[1, 9]
- Startup Rationalization: While legacy players have pulled back, more aggressive competitors like Devoted Health are experiencing explosive growth.[25] If competitors engage in "benefit wars" by subsidizing losses with venture capital, Alignment might be forced to cut margins to maintain its membership targets.[25]
Regulatory or Legal Risks
- CMS Star Rating Methodology: CMS is fundamentally "resetting" the Star Ratings methodology.[38] The weight of operational measures is decreasing while patient experience and behavioral health are increasing.[38, 39] A decline from 4.0 to 3.5 stars in any major contract would be catastrophic, as it would eliminate the Quality Bonus Payments that fund Alignment's benefit-rich plans.[24, 38]
- V28 Risk Model Transition: The multi-year transition to the V28 coding model is a persistent headwind for the entire industry.[9] While Alignment claims to be "on plan," any miscalculation in how chronic conditions are coded under the new rules could lead to lower-than-expected revenue per member.[9, 21]
- Governmental Policy Shifts: The Medicare Advantage program is subject to political whims. If future administrations significantly reduce overpayments to MA plans—which some reports estimate totaled $80 billion in 2025—Alignment’s entire economic model could be under threat.[40]
Macroeconomic Sensitivities
- Medical Inflation vs. CMS Rates: If medical inflation (driven by nurse wages and drug prices) exceeds the 2.48% CMS rate increase for 2026/2027, Alignment’s margins will be squeezed.[21, 28, 40]
- Interest Rates: While Alignment has strong cash reserves, a "higher for longer" interest rate environment increases the hurdle rate for expansion and impacts the valuation multiples of high-growth healthcare stocks.[5, 32]
Risk Triage: Early Warning Signs
| Risk Event |
Early Warning Sign |
Long-Term Thesis Impact |
| Star Rating Downgrade |
Preliminary CMS Star data in October showing a drop to 3.5 stars. |
Severe: Likely ends the "virtuous cycle" of growth. |
| Utilization Spike |
Medical expenses payable rising faster than revenue on the balance sheet. |
High: Indicates clinical model failure or unexpected acuity. |
| Market Share Loss |
Voluntary disenrollment rate rising above 10% in AEP. |
Moderate: Suggests loss of brand/concierge edge. |
NAVIGATING REGULATORY VOLATILITY
5. 5-Year Scenario Analysis:
Developing a five-year outlook for Alignment Healthcare requires a careful calibration of membership growth, medical benefit management, and the successful scaling of automation. The current share price of $17.93 serves as the baseline for this analysis.[30, 31]
High Case: The Medicare Advantage Standard (Probability: 25%)
In the High Case, Alignment leverages its superior technology to become the industry standard for value-based care. As national players like Humana continue to struggle with their Star Ratings, Alignment captures a larger-than-expected share of the 1 million new MA beneficiaries entering the market each year.[25, 29]
* Fundamentals: Membership reaches 1 million by 2031 (Management's long-term goal).[16] Revenue CAGR remains at 35% as the company enters 15 new states.
* Profitability: MBR falls to 86% due to extreme AI-driven precision. SG&A drops to 7.5% through 90%+ claims automation.[12, 16]
* Valuation: The market awards ALHC a premium EBITDA multiple of 22x, similar to high-growth tech firms, as it proves a "software-like" scalability in healthcare.
* Implied Share Price: ~$38.50.
Base Case: Disciplined Scaling (Probability: 55%)
The Base Case assumes the company continues its current trajectory, successfully expanding into its existing counties and 2-3 new states per year.
* Fundamentals: Membership grows at a steady 22% CAGR, reaching ~750,000 members by 2031.[11, 34] Revenue CAGR sits at 25%.
* Profitability: MBR remains stable at 87.5%. SG&A improves to 8.2% of revenue as the company achieves economies of scale in its newer markets.[9, 16]
* Valuation: An 18x EV/EBITDA multiple is applied, reflecting a mature but still high-growth managed care organization.
* Implied Share Price: ~$26.25.
Low Case: The Regulatory Squeeze (Probability: 20%)
In the Low Case, CMS implements further cuts to MA rates, and the methodology shift in Star Ratings causes Alignment’s core California contract to slip to 3.5 stars.[24, 38]
* Fundamentals: Membership growth stalls at 12% as the company is forced to reduce benefits to stay afloat.[40] Revenue CAGR falls to 15%.
* Profitability: MBR rises to 90% due to adverse selection in new markets. SG&A remains stuck at 9.5% because of increased compliance costs.[9, 40]
* Valuation: A conservative 12x EV/EBITDA multiple is used, reflecting a low-growth, high-risk insurance entity.
* Implied Share Price: ~$13.50.
5-Year Scenario Comparison Table
| Scenario |
Rev/Membership in Yr 5 |
Margin/Earnings Assumption |
Valuation Multiple |
Current Price |
Implied Price |
5-Yr Total Return |
Annualized Return |
Prob |
| High |
$25B / 1.0M |
8.5% EBITDA Margin |
22x EV/EBITDA |
$17.93 |
$38.50 |
114.7% |
16.5% |
0.25 |
| Base |
$16B / 0.75M |
6.5% EBITDA Margin |
18x EV/EBITDA |
$17.93 |
$26.25 |
46.4% |
8.0% |
0.55 |
| Low |
$10B / 0.45M |
3.5% EBITDA Margin |
12x EV/EBITDA |
$17.93 |
$13.50 |
-24.7% |
-5.5% |
0.20 |
Weighted Average Price Target: $26.76
Data inputs derived from:.[11, 13, 16, 17, 25, 29, 34]
ASYMMETRIC GROWTH OPPORTUNITY
6. Qualitative Scorecard:
Each metric is scored on a scale of 1–10.
- Management Alignment (9/10): Founder John Kao’s leadership and the 10-year consistency of the "Seniors First" model are exceptional.[1, 3] Executive pay is 50% PSUs tied to revenue and EBITDA, and Kao recently received 338k RSUs vesting over 3 years, ensuring his long-term focus.[7, 37]
- Revenue Quality (9/10): Almost 100% of revenue is government-backed through CMS.[5, 6] The high-acuity member mix (C-SNP/D-SNP) provides defensive qualities as these members are less likely to switch plans and have predictable cost profiles when managed correctly.[8, 17]
- Market Position (8/10): Alignment is winning market share, growing at 31% while the industry averages 2.5%.[15, 25] However, it is still a "David" among "Goliaths," necessitating high capital intensity to continue expansion.[10, 27]
- Growth Outlook (9/10): The pathway to 1 million members is supported by a massive TAM and current market share under 4% in non-CA counties.[9, 11, 16]
- Financial Health (8/10): Turning GAAP profitable in Q1 2026 is a game-changer.[12, 13] Liquidity of $726M and a leverage ratio of 2.6x EBITDA indicate a sustainable balance sheet.[16, 21]
- Business Viability (8/10): The AVA platform and 24/7 concierge model provide high durability.[2, 4] The main choke point is regulatory—specifically, the dependency on CMS Star Rating methodology.[38, 41]
- Capital Allocation (7/10): Management has focused on organic growth and automation infrastructure ($40M capex).[16, 17] However, the March 2026 secondary offering by General Atlantic creates a potential headwind for the share price.[36, 42]
- Analyst Sentiment (9/10): Broad consensus of "Moderate Buy" to "Strong Buy" with a $24.60-$25.54 target price range.[43, 44, 45]
- Profitability (6/10): While positive, the net profit margin is still thin (0.9%).[28, 33] The company is just entering the "harvest" phase of its life cycle.[16, 35]
- Track Record (8/10): Alignment has consistently beaten its own guidance and analyst estimates for several consecutive quarters.[12, 15, 35]
Overall Blended Score: 8.1 / 10
BEST-IN-CLASS DISRUPTOR
7. Conclusion & Investment Thesis:
Alignment Healthcare Inc (ALHC) represents a rare combination of high-velocity growth and an emerging track record of profitability in a complex, defensive sector.[12, 28, 33] The investment thesis rests on the company’s ability to use its proprietary AVA® technology to manage medical costs more effectively than legacy competitors, thereby capturing the high-value "Quality Bonus Payments" from CMS.[2, 4, 15]
As the Medicare Advantage market continues to mature and legacy giants struggle with rising utilization, Alignment’s high-touch, concierge-led clinical model is proving to be the "model of the future".[9, 25] The transition to GAAP profitability in Q1 2026, combined with the aggressive automation of its administrative backbone, suggests that the company has reached a critical inflection point where revenue growth can lead to exponential earnings expansion.[16, 17]
Significant upcoming catalysts include the inclusion in the S&P SmallCap 600 index and the potential for a positive "sweep" adjustment in risk-adjustment revenue later in 2026.[16, 46] While regulatory risks and geographic concentration in California must be monitored, the current valuation at less than 1x sales provides an attractive entry point for investors seeking exposure to a disruptive healthcare platform that is finally scaling profitably.[30, 32] PROFITABLE GROWTH INFLECTION
8. Technical Analysis, Price Action & Short-Term Outlook:
Alignment Healthcare is currently trading at $17.93, roughly 2% below its 200-day simple moving average of $18.26, indicating a consolidation phase after a 33% six-month run.[12, 31, 47] While recent news of a secondary offering and some cautious post-earnings sentiment led to a temporary 5% slump, the fundamental turnaround and impending S&P index inclusion should provide a strong technical floor.[36, 46, 48] Short-term resistance is observed at $19.45, while a decisive move above the 50-day moving average of $19.38 could signal a breakout toward analyst targets of $25.00+.[47, 49, 50] TECHNICAL CONSOLIDATION PHASE
- Alignment Healthcare, Inc. - BriefGlance.com, https://briefglance.com/companies/alignment-healthcare-inc
- Alignment Healthcare's AVA® Technology Platform Powers More Than 1 Million Personalized Care Interactions to Date, https://ir.alignmenthealth.com/news-releases/news-release-details/alignment-healthcares-avar-technology-platform-powers-more-1/
- About Us - Alignment Health, https://www.alignmenthealth.com/about-us
- Our Offerings | Alignment Health, https://www.alignmenthealth.com/partners/our-offerings
- Alignment Healthcare (ALHC) turns profitable as revenue and membership surge, https://www.stocktitan.net/sec-filings/ALHC/10-q-alignment-healthcare-inc-quarterly-earnings-report-28de0129fb68.html
- ALHC SEC Filings - Alignment Healthcare, Inc. 10-K, 10-Q, 8-K Forms - Stock Titan, https://www.stocktitan.net/sec-filings/ALHC/
- Alignment Healthcare (ALHC) proxy outlines 2025 growth, governance and executive pay structure - Stock Titan, https://www.stocktitan.net/sec-filings/ALHC/def-14a-alignment-healthcare-inc-definitive-proxy-statement-8afc7877716f.html
- Alignment Health Unveils 2026 Medicare Advantage Plans with Strong Benefits, Expanded Support for Seniors, https://ir.alignmenthealth.com/news-releases/news-release-details/alignment-health-unveils-2026-medicare-advantage-plans-strong/
- Alignment (ALHC) Q4 2025 Earnings Call Transcript | The Motley Fool, https://www.fool.com/earnings/call-transcripts/2026/02/26/alignment-alhc-q4-2025-earnings-call-transcript/
- Alignment Healthcare's idiosyncratic take on Medicare Advantage, https://www.healthcaredive.com/news/alignment-healthcare-john-kao-medicare-advantage/814907/
- Medicare Advantage Done Right, https://ir.alignmenthealth.com/static-files/084417c3-f12b-4297-82fd-4ddfef61c6a2
- Earnings call transcript: Alignment Healthcare Q1 2026 beats expectations - Investing.com, https://www.investing.com/news/transcripts/earnings-call-transcript-alignment-healthcare-q1-2026-beats-expectations-93CH-4651712
- Alignment Healthcare Q1 2026 revenue jumps 33%, turns profitable | ALHC 8-K Filing, https://www.stocktitan.net/sec-filings/ALHC/8-k-alignment-healthcare-inc-reports-material-event-46b9396f9139.html
- Members | Alignment Health, https://www.alignmenthealth.com/members
- Alignment Healthcare Reports 31% Year-Over-Year Membership Growth to 275300 as of Jan. 1, 2026 - Investor Relations, https://ir.alignmenthealth.com/news-releases/news-release-details/alignment-healthcare-reports-31-year-over-year-membership-growth/
- Alignment (ALHC) Q1 2026 Earnings Transcript | The Motley Fool, https://www.fool.com/earnings/call-transcripts/2026/05/01/alignment-alhc-q1-2026-earnings-transcript/
- Alignment Healthcare Q1 Earnings Call Highlights - MarketBeat, https://www.marketbeat.com/instant-alerts/alignment-healthcare-q1-earnings-call-highlights-2026-04-30/
- 2026, https://resources.finalsite.net/images/v1760384138/cusdk8org/ov142ewoqdyb2njkhe6v/2026AlignmentHealthSummary_v5_508.pdf
- Summary of Benefits 2026, https://content.sunfirematrix.com/2026/Alignment-2026-Summary-of-Benefits-NV-H5296-007-008-HMO-EN-508-SB-SF20250917.pdf
- Alignment Health, https://www.alignmenthealth.com/
- Alignment Healthcare forecasts $138M-$163M adjusted EBITDA for 2026 as membership outlook ... - Seeking Alpha, https://seekingalpha.com/news/4583611-alignment-healthcare-forecasts-138m-163m-adjusted-ebitda-for-2026-as-membership-outlook-rises
- Healthcare Provider Embraces Digital To Navigate Turbulent Times - Forbes, https://www.forbes.com/sites/joemckendrick/2021/09/25/healthcare-provider-embraces-digital-to-navigate-turbulent-times/
- Alignment Healthcare Delivers Strong First Quarter 2026 Results, Demonstrating Disciplined Growth and Margin Expansion, https://ir.alignmenthealth.com/news-releases/news-release-details/alignment-healthcare-delivers-strong-first-quarter-2026-results/
- 2026 Medicare Advantage Star Ratings: How Insurers Fared - Certifi, Inc., https://www.certifi.com/blog/2026-medicare-advantage-star-ratings-how-insurers-fared/
- Medicare Advantage enrollment depicts industry at a crossroads - HealthScape Advisors, https://www.healthscape.com/insights/medicare-advantage-enrollment-depicts-industry-crossroads
- 2024 Medicare Advantage Enrollment Databook - ATI Advisory, https://atiadvisory.com/resources/wp-content/uploads/2024/03/2024-Medicare-Advantage-Enrollment-Databook.pdf
- Medicare Advantage Market Size & Share [2034], https://www.marketreportsworld.com/market-reports/medicare-advantage-market-14724028
- Alignment Healthcare (NasdaqGS:ALHC) - Earnings & Revenue Performance, https://simplywall.st/stocks/us/healthcare/nasdaq-alhc/alignment-healthcare/past
- Alignment Healthcare (ALHC) Stock Forecast: Analyst Ratings, Predictions & Price Target 2026, https://public.com/stocks/alhc/forecast-price-target
- Alignment Healthcare (ALHC) Stock Price, News & Analysis - MarketBeat, https://www.marketbeat.com/stocks/NASDAQ/ALHC/
- ALHC - Alignment Healthcare, Inc. Stock - Stock Price, Institutional Ownership, Shareholders (NasdaqGS) - Fintel, https://fintel.io/so/us/alhc
- Alignment Healthcare (ALHC) - Trefis, https://www.trefis.com/data/companies/ALHC
- The Top 5 Analyst Questions From Alignment Healthcare's Q1 Earnings Call - Barchart.com, https://www.barchart.com/story/news/1761908/the-top-5-analyst-questions-from-alignment-healthcares-q1-earnings-call
- ALHC Stock Forecast - Alignment Healthcare LLC - Alpha Spread, https://www.alphaspread.com/security/nasdaq/alhc/analyst-estimates
- Alignment Healthcare Reports Fourth Quarter and Full-Year 2025 Results; Beats High-End of Guidance Across All Key Metrics - Investor Relations, https://ir.alignmenthealth.com/news-releases/news-release-details/alignment-healthcare-reports-fourth-quarter-and-full-year-2025/
- Alignment Healthcare Announces Pricing of Secondary Offering - Stock Titan, https://www.stocktitan.net/news/ALHC/alignment-healthcare-announces-pricing-of-secondary-rx2kdea3opky.html
- Alignment Healthcare CEO granted 338,434 RSUs | ALHC Insider Trading - Stock Titan, https://www.stocktitan.net/sec-filings/ALHC/form-4-alignment-healthcare-inc-insider-trading-activity-6f0be51f8fd7.html
- Are you ready? CMS just ignited the biggest Stars shake-up in a decade | Press Ganey, https://www.pressganey.com/resources/blog/cms-stars-shake-up/
- 2026 Star Ratings Fact Sheet | CMS, https://www.cms.gov/files/document/2026-star-ratings-fact-sheet.pdf
- The 2026 Medicare Advantage Market is Healthy and Can Absorb Needed Payment Changes, https://assets.arnoldventures.org/uploads/PDFs/Summary-MA-Landscape.pdf
- CMS Star Ratings in 2026: Why Quality May Not Reflect Care | UASI, https://www.uasisolutions.com/cms-star-ratings-2026-performance-gap
- Form 424B7 for Alignment Healthcare INC filed 03/03/2026, https://ir.alignmenthealth.com/static-files/50fdbced-b258-45fd-b329-1f5e64aa7d9e
- Alignment Healthcare (ALHC) Stock Forecast and Price Target 2026 - MarketBeat, https://www.marketbeat.com/stocks/NASDAQ/ALHC/forecast/
- What is the current Price Target and Forecast for Alignment Healthcare (ALHC), https://www.zacks.com/stock/research/ALHC/price-target-stock-forecast
- Alignment Healthcare LLC (ALHC) Stock Forecast & Price Target - Investing.com, https://www.investing.com/equities/alignment-healthcare-llc-consensus-estimates
- Alignment Healthcare Set to Join S&P SmallCap 600 - May 11, 2026 - Press Releases, https://press.spglobal.com/2026-05-11-Alignment-Healthcare-Set-to-Join-S-P-SmallCap-600
- ALHC Technical Analysis for Alignment Healthcare Stock - Barchart.com, https://www.barchart.com/stocks/quotes/ALHC/technical-analysis
- Alignment Healthcare, Inc. Stock Price: Quote, Forecast, Splits & News (ALHC) - Perplexity, https://www.perplexity.ai/finance/ALHC
- Alignment Healthcare (NASDAQ:ALHC) Shares Down 6.1% - Here's Why - MarketBeat, https://www.marketbeat.com/instant-alerts/alignment-healthcare-nasdaqalhc-shares-down-61-heres-why-2026-05-05/
- Alignment Healthcare, Inc. (ALHC) Stock Analysis: A 45.63% Upside Potential Sparks Investor Interest - DirectorsTalk Interviews, https://www.directorstalkinterviews.com/alignment-healthcare-inc-alhc-stock-analysis-a-45-63-upside-potential-sparks-investor-interest/4121246054